Effectiveness of Acupuncture in Relieving Pain Due to Fibromyalgia
Mechanisms of Acupuncture Analgesia
2 other identifiers
interventional
46
1 country
1
Brief Summary
This study will determine the effectiveness of acupuncture versus a placebo in altering brain activity and relieving pain due to fibromyalgia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started May 2005
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 1, 2005
CompletedFirst Posted
Study publicly available on registry
September 2, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedResults Posted
Study results publicly available
April 13, 2015
CompletedApril 13, 2015
December 1, 2014
5.8 years
September 1, 2005
December 4, 2014
April 9, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Mu-opioid Receptor Occupancy
Here we report the change (post - pre) in mu-opioid receptor binding potential (BP) for the perigenual anterior cingulate. BP is a unitless measure and reflects the total maximum binding of receptors divided by the dissociation constant. BP = Bmax/Kd.
measured from baseline to week 5
Study Arms (2)
Traditional Acupuncture
ACTIVE COMPARATORAcupuncture sites will be used for active intervention.
Sham Treatment
SHAM COMPARATORSham acupuncture is used.
Interventions
Involves the insertion and manual stimulation of thin acupuncture needles into specific points in the body. Fibromyalgia participants will be randomized to receive 9 acupuncture treatments over the course of four weeks. All participants will be scanned twice using the fMRI scanner. The PET portion of the study is optional.
Fibromyalgia participants will be randomized to receive 9 sham treatments over the course of four weeks. All participants will be scanned twice using the fMRI scanner. The PET portion of the study is optional.
Eligibility Criteria
You may qualify if:
- Has met American College of Rheumatology (1990) criteria for the diagnosis of fibromyalgia for at least 1 year
- Chronic pain more than 50% of days
- Willing to limit introduction of any new medications or treatments for fibromyalgia during the study
- Able to attend study visits up to three times weekly
- Right-handed
- Must be within driving distance of Ann Arbor, MI
- Willing to refrain from alcohol intake for 48 hours prior to PET studies
You may not qualify if:
- Knowledge that could prevent "blinding" of the participant to the study interventions (including previous acupuncture treatment)
- Presence of a known coagulation abnormality, thrombocytopenia, or bleeding diathesis that may preclude the safe use of acupuncture
- Autoimmune or inflammatory disease (in addition to fibromyalgia) that causes pain (e.g., rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease)
- Daily use of narcotic pain-relievers
- History of substance abuse
- Simultaneous participation in other therapeutic trials
- Pregnant or breastfeeding
- Current severe psychiatric illness (e.g., schizophrenia, major depression with suicidal ideation)
- Condition that may make exposure to fMRI medically inadvisable
- Any condition that may prevent satisfactory completion of the study protocol
- Current major depression
- Condition that may make exposure to PET medically inadvisable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
Related Publications (1)
Harris RE, Sundgren PC, Pang Y, Hsu M, Petrou M, Kim SH, McLean SA, Gracely RH, Clauw DJ. Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. Arthritis Rheum. 2008 Mar;58(3):903-7. doi: 10.1002/art.23223.
PMID: 18311814DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Richard E. Harris
- Organization
- University of Michigan
Study Officials
- PRINCIPAL INVESTIGATOR
Richard E. Harris, PhD
University of Michigan
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 1, 2005
First Posted
September 2, 2005
Study Start
May 1, 2005
Primary Completion
March 1, 2011
Study Completion
March 1, 2011
Last Updated
April 13, 2015
Results First Posted
April 13, 2015
Record last verified: 2014-12